DK0869808T3 - Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation - Google Patents

Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation

Info

Publication number
DK0869808T3
DK0869808T3 DK96934021T DK96934021T DK0869808T3 DK 0869808 T3 DK0869808 T3 DK 0869808T3 DK 96934021 T DK96934021 T DK 96934021T DK 96934021 T DK96934021 T DK 96934021T DK 0869808 T3 DK0869808 T3 DK 0869808T3
Authority
DK
Denmark
Prior art keywords
glu
drug
preparation
treatment
various conditions
Prior art date
Application number
DK96934021T
Other languages
Danish (da)
English (en)
Inventor
Lawrence R Green
John W Blasecki
Original Assignee
Cytran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytran Ltd filed Critical Cytran Ltd
Application granted granted Critical
Publication of DK0869808T3 publication Critical patent/DK0869808T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96934021T 1995-10-03 1996-10-02 Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation DK0869808T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53870195A 1995-10-03 1995-10-03
US08/614,764 US5902790A (en) 1995-10-03 1996-03-13 Pharmaceutical angiostatic dipeptide compositions and method of use thereof

Publications (1)

Publication Number Publication Date
DK0869808T3 true DK0869808T3 (da) 2006-11-13

Family

ID=27065900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96934021T DK0869808T3 (da) 1995-10-03 1996-10-02 Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation

Country Status (23)

Country Link
US (4) US5902790A (de)
EP (1) EP0869808B1 (de)
JP (2) JP3679129B2 (de)
KR (1) KR100483779B1 (de)
CN (1) CN1128636C (de)
AT (1) ATE332702T1 (de)
AU (1) AU714846B2 (de)
BR (1) BR9610838A (de)
CA (1) CA2233457C (de)
CZ (1) CZ298345B6 (de)
DE (1) DE69636343T2 (de)
DK (1) DK0869808T3 (de)
EA (1) EA001146B1 (de)
ES (1) ES2268710T3 (de)
HU (1) HUP9902105A3 (de)
IL (1) IL123889A0 (de)
MX (1) MX9802564A (de)
NO (1) NO326298B1 (de)
NZ (1) NZ319907A (de)
PL (1) PL186123B1 (de)
SK (1) SK283677B6 (de)
TR (1) TR199800653T1 (de)
WO (1) WO1997012625A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US6060452A (en) * 1996-03-13 2000-05-09 Cytran, Inc. Analogs of L-Glu-L-Trp having pharmacological activity
WO1999051720A2 (en) * 1998-04-03 1999-10-14 Cytran Ltd. Methods for production of therapeutic cytokines
EP1311269B1 (de) 2000-08-04 2012-02-29 DMI Biosciences, Inc. Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
DE10100052A1 (de) * 2001-01-02 2002-07-11 Inst Medizintechnologie Magdeb Kombinierte Verwendung von Enzyminhibitoren und pharmazeutischen Zubereitungen daraus zur Therapie und Prophylaxe der Atheriosklerose
US7229969B2 (en) * 2001-01-02 2007-06-12 Imtm Gmbh Combinations of enzyme inhibitors and the use thereof
US20030087830A1 (en) * 2001-06-12 2003-05-08 Eric Dupont Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
WO2005016326A2 (en) * 2003-07-11 2005-02-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
EP1663223B1 (de) 2003-09-17 2014-01-01 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Thalidomid-analoga als tnf-alpha-modulatoren
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
CA2569204A1 (en) * 2006-11-28 2008-05-28 Apotex Technologies Inc. Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan
CA2571645A1 (en) * 2006-12-19 2008-06-19 Apotex Technologies Inc. Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
UA96980C2 (ru) * 2007-02-13 2011-12-26 Сайклон Фармасютикалс, Инк. Способ уменьшения степени ухудшения состояния, поражения или повреждения слизистой оболочки
CA2579119C (en) 2007-02-16 2013-03-05 Apotex Technologies Inc. Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
UA98508C2 (ru) * 2007-08-23 2012-05-25 Сайклон Фармасьютикалз, Инк. Иммуномодуляторное производное дипептида для лечения рака легких
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
DE102008032828A1 (de) * 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
JP2013537195A (ja) 2010-09-07 2013-09-30 ディエムアイ アクイジション コーポレイション 疾患の治療
MX2014003856A (es) 2011-10-10 2015-01-16 Ampio Pharmaceuticals Inc Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos.
CN103841987B (zh) 2011-10-10 2015-06-17 安皮奥制药股份有限公司 退行性关节病的治疗
SG10201605205VA (en) 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
CN102631464B (zh) * 2012-05-18 2013-07-31 崔新明 一种治疗婴幼儿血管瘤的中药膏剂及其制备方法
EP2968315B1 (de) 2013-03-15 2020-06-03 Ampio Pharmaceuticals, Inc. Zusammensetzungen für mobilisierung, homing, expansion und differenzierung von stammzellen und verfahren zur verwendung davon
EP3183240A4 (de) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Behandlung von gelenkerkrankungen
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
JP2020532586A (ja) 2017-08-31 2020-11-12 シンガポール ヘルス サービシーズ プライベート リミテッド 網膜血管性疾患の処置のためのａｎｇｉｏ−３

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997516A (en) * 1974-07-04 1976-12-14 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
US4191753A (en) * 1978-11-06 1980-03-04 University Of Miami Anti-hypertensive peptide analogs
WO1989006134A1 (en) * 1987-12-30 1989-07-13 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademi Pharmaceutical preparation for treating immunodeficiency conditions
US5728680A (en) * 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
SU1642398A1 (ru) * 1988-12-21 1991-04-15 Ростовский медицинский институт Способ лечени синуитов у детей
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
RU1827255C (ru) * 1990-10-22 1993-07-15 Киевский государственный институт усовершенствования врачей Способ лечени туберкулеза легких
JP3068656B2 (ja) * 1991-03-07 2000-07-24 アピ株式会社 新規なペプチド及びアンジオテンシン変換酵素阻害ペプチド並びにそれらを含有する経口摂食組成物
AU668088B2 (en) * 1991-04-01 1996-04-26 Cytran Ltd. Pharmaceutical dipeptide compositions and methods of use thereof
RU2014063C1 (ru) * 1991-04-23 1994-06-15 Сочинский научно-исследовательский институт курортологии и физиотерапии Способ лечения подострых воспалительных заболеваний гениталий
DE69230500D1 (de) * 1991-10-28 2000-02-03 Cytran Ltd Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
EP0745091A4 (de) * 1993-09-24 1998-05-20 Univ Southern California Verwendung von angiotensin ii analogen in der gewebewiederherstellung

Also Published As

Publication number Publication date
NO326298B1 (no) 2008-11-03
NZ319907A (en) 2000-09-29
IL123889A0 (en) 1998-10-30
ES2268710T3 (es) 2007-03-16
HUP9902105A2 (hu) 1999-09-28
NO981436L (no) 1998-05-19
DE69636343T2 (de) 2007-07-19
MX9802564A (es) 1998-11-30
CN1198673A (zh) 1998-11-11
JP2005194287A (ja) 2005-07-21
BR9610838A (pt) 1999-12-21
CA2233457C (en) 2004-08-03
SK42398A3 (en) 1998-10-07
US5902790A (en) 1999-05-11
US6911431B1 (en) 2005-06-28
JP3679129B2 (ja) 2005-08-03
ATE332702T1 (de) 2006-08-15
KR100483779B1 (ko) 2007-03-02
US20060094665A1 (en) 2006-05-04
JPH11504943A (ja) 1999-05-11
TR199800653T1 (xx) 1998-06-22
EA001146B1 (ru) 2000-10-30
KR19990063958A (ko) 1999-07-26
CA2233457A1 (en) 1997-04-10
SK283677B6 (sk) 2003-11-04
EP0869808B1 (de) 2006-07-12
EP0869808A1 (de) 1998-10-14
CZ298345B6 (cs) 2007-09-05
NO981436D0 (no) 1998-03-30
CZ91398A3 (cs) 1998-11-11
WO1997012625A1 (en) 1997-04-10
AU7254096A (en) 1997-04-28
PL186123B1 (pl) 2003-10-31
AU714846B2 (en) 2000-01-13
EA199800357A1 (ru) 1998-10-29
HUP9902105A3 (en) 2001-02-28
CN1128636C (zh) 2003-11-26
DE69636343D1 (de) 2006-08-24
PL326149A1 (en) 1998-08-31
US6096713A (en) 2000-08-01

Similar Documents

Publication Publication Date Title
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
NO20013727L (no) Anvendelse av Botulinumtoksin B for fremstilling av et medikament
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IS2537B (is) Lyfjablanda til inngjafar um húð
NO20053104D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
DK0932388T3 (da) Doseringsform og fremgangsmåde til indgivelse af lægemidler
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
DK1039900T3 (da) Farmaceutisk præparat indeholdende sibutramin og orlistat
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
RU96104214A (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
RU96124465A (ru) Способ лечения стойких дезадаптационных психовегетативных расстройств